Skip to main content
BMC Women's Health logoLink to BMC Women's Health
. 2020 Apr 6;20:70. doi: 10.1186/s12905-020-00927-5

Socio-demographic characteristics and associated factors influencing cervical cancer screening among women attending in St. Paul’s Teaching and Referral Hospital, Ethiopia

Abebe Belete Woldetsadik 1,#, Abebe Feyissa Amhare 1,#, Sintayehu Tsegaye Bitew 1, Leilei Pei 1, Jian Lei 1, Jing Han 2,
PMCID: PMC7137499  PMID: 32252733

Abstract

Background

In Ethiopia, cervical cancer is the second most frequent cancer among women aged 15 to 44 years old. Cervical cancer screening is an effective measure to enhance the early detection of cervical cancer for prevention. However, the magnitude of cervical cancer screening is less than 1%. This study aimed to determine the influence of sociodemographic characteristics and related factors on screening.

Method

A hospital-based cross-sectional study has been conducted from July to September 2017. Data have been collected using interviewer-administered questioner among 425 women (18–49 years age) who visited the family health department at St. Paul’s Hospital. Descriptive statistics, chi-square, univariate and multivariate logistic regression were used for data analysis.

Result

Of the 425 study participants, only 12.2% of women have been screened within the past 3 years. Women in the age range of 40–49 years old were more likely to be screened (36.1%) than women age 18–29 years (8%). Women living in urban were more likely to be screened (15.9%) than women living in rural (3.9%). Other factors including low monthly income, unlikely chance of having cancer, lack of knowledge, and fear test outcome were significantly associated with the low uptake of screening.

Conclusion

This study revealed that the uptake of cervical cancer screening was low. Women in the potential target population of cervical cancer screening were just a proportion of all studied age groups and screening in them was more common than in younger women. Besides, rural residence, low monthly income, and lack of knowledge were important predictors for low utilization of cervical cancer screening practice.

Keywords: Cervical cancer, Factors, Screening, Sociodemographic characteristics, Women

Background

Cervical cancer is one of the most public health burdens in the world [1, 2]. Globally, more than 569,000 new cervical cancer and 311,000 women death by cervical cancer have been reported annually by the International Agency for Research on Cancer (IARC) Global Cancer Observatory [2, 3]. In Africa, more than 119,000 new cervical cases and 81,000 deaths of cervical cancer have been reported annually by IARC Global Cancer Observatory [2]. Over the past 30 years, the incidence and mortality rate of cervical cancer has been increased every year by 0.6 and 0.46% respectively [4]. In Sub-Saharan Africa countries, cervical cancer comprises 20 to 25% of total cancer cases, which is two times that of women in the world [5]. World Health Organization (WHO) has reported that low and middle-income countries are taking the highest burden of cervical cancer. This is mainly due to lack of effective screening schedules and limited uptake of pelvic examination [6].

In Ethiopia, over 27.19 million females who are 15 years and above are at risk to develop cervical cancer [7]. The recent study estimated that there are annually 6294 new cases and 4884 cervical cancer deaths in Ethiopia [2]. It is the second most frequent cancer among women 15 to 44 years old. Despite this fact, less than 1% of women underwent cervical cancer screening every 3 years [7, 8]. Ethiopia has no separate cervical cancer prevention and control program; it has been done together with the reproductive care system until recent years [9]. In 2009, the Federal Ministry of Health (FMOH) collaboration with Pathfinder International had established a pilot project to provide the service in 14 health institutions in different regions of the country. Since 2015, FMOH has launched a new directive guideline to scale up cervical cancer prevention and control program by health workers and concerned stockholders to implement the program; Visual Inspection Acetic acid (VIA) and cytology test were used as a national cervical cancer screening approach [10].

The previous study also reported that Human Papilloma Virus (HPV) infection, multiple sexual partners, smoking, high parity, long-term hormonal contraceptive use, and co-infection with Human Immune deficiency Virus (HIV) as risk factors of cervical cancer [11].

Cervical cancer progression depends on the stage of a patient at first contact at the health facility. In developing countries including Ethiopia, most patients are coming to the health facility after the advanced stage of the disease [12, 13]. Therefore, the improvement is becoming reduced even using multiple treatment modalities, such as surgery, radiology or chemotherapy. Several reasons are noted in different studies; for instance, location, access to the health facility, educational level, financial capability, and later visit of their doctor [13, 14].

Effective screening program reduces the incidence and mortality of cervical cancer as the disease is potentially preventable [1517]. In developed countries, routine cervical cancer screening prevents up to 80% through early detection and management of pre-cancerous cervical lesions [1820]. Whereas in developing countries, the proportion of pelvic examination was very low (< 1% in Ethiopia to 23% in South-Africa) [18]. These differences are due to different factors like financial constraints, complex structural and cultural issues [21]. Women have differed in cervical screening even with a similar opportunity in Ethiopia. Besides, there is no plenty of literature related to this topic found in Ethiopia. Therefore, the purpose of this study is to determine the influence of socio-demographic characteristics and related factors on cervical screening among women who attended St. Paul’s teaching and referral hospital, Ethiopia.

Methods

Study design and study area

The hospital-based cross-sectional study design has been conducted from July to September 2017 at the family health department of St. Paul’s Teaching and Referral Hospital (SPTRH). SPTRH is one of the specialized referral hospitals located in Addis Ababa, the capital city of Ethiopia. This hospital has been serving over five million catchment population living in urban, semi-urban and rural areas.

Sample size determination and sampling

Based on available hospital registration records, approximately about 16,800 women aged 18–49 years visit the outpatient clinic provide service at the family health department per year.

The required sample size was estimated using a single population proportion formula with 95% CI, 5% margin of error, and 50% of population proportion was assumed as the prevalence of screening to maximize sample size because the prevalence of previous studies was very small. By adding a 10% non-response rate, the total calculated sample size was 425. Since the study group of the population was dynamic, purposive sampling method was used to select 425 women based on arrival record book using inclusion criteria (women aged ≥18 and less than or equal to 49 years, voluntariness, and who visited outpatient clinic during the study period) and exclusion criteria (women who had hysterectomy and seriously ill) were selected until the required sample was achieved.

Data collection technique

Quantitative data were collected using an interviewer-administered questionnaire concerning cervical cancer and screening. Cervical cancer screening within the last 3 years was considered as the outcome variable (1 for the screen, and 0 for unscreened). A predictive variable of interest includes socio-demographic characteristics (age, income, occupation, residence, parity, religion, marital status, and educational level), knowledge, and perception towards cervical cancer and its screening, exposure status for the risk factor, and barriers concerning cervical cancer screening. The questionnaire was adopted from a standardized questionnaire [22] and contextualized based on the study objective. Initially, the questionnaire was developed in English and translated into local language, Amharic by language experts. A pilot study had been carried out among 22 participants before actual study, and an amendment was done accordingly. Trained nurses had collected the data using face to face interview.

Data analysis

Data were double entered into Epi-data version 3.0 and transported to SPSS version 24.0 for analysis. Descriptive information was presented using tables and figure. Frequency and percentage were performed to compute the proportion of groups among the study participants. Chi-square analysis was used to determine the association between predictors and outcome variables. Univariate and multivariate logistic regression were used and a P value of less than 0.2 in univariate analysis was entered to multivariate logistic regression analysis to adjust the effect of confounders to the outcome variable. Odds ratios with 95% Confidence Intervals were computed; a P value < 0.05 was considered as statistically significant.

Results

Sociodemographic characteristics of the study participants

A total of 425 respondents (response rate 100%) had participated in this study. Of 425 respondents, 202 (47.5%) participants were 30–39 years age, 333 (78.4%) were married, and 169 (39.8%) were housewives. More than one-quarter of respondents (29.6%) were attended primary education and 55.3% had one or two births. More than 30 % (30.4%) of participants were residing in the rural area and 20.1% had no access to screening in a nearby health facility. More than half of respondents (55.2%) had monthly income less than 2000 Ethiopia Birr (75 USA dollars) (Table 1).

Table 1.

Socio-demographic characteristics of respondents (n = 425)

Characteristics Frequency (n) Percent (%)
Age in year
 18–29 187 44.0
 30–39 202 47.5
 40–49 36 8.5
Marital status
 Single 75 17.6
 Married 333 78.4
 Divorce/ Windowed 17 4.0
Religion
 Orthodox 272 64.0
 Muslim 85 20.0
 Protestant 61 14.4
 Other 7 1.6
Educational status
 Primary & below 126 29.6
 Secondary & higher 299 70.4
Occupational status
 Governmental employee 94 22.1
 Self-employed 162 38.1
 Housewife 169 39.8
Parity
 Nulliparous 134 31.5
 1–2 birth 235 55.3
 3 & above 56 13.2
Residence
 Urban 296 69.6
 Rural 129 30.4
Monthly income
 < 2000 Birr 235 55.3
 2000–3999 Birr 105 24.7
 4000+ 85 20.0

Association between socio-demographic characteristics and cervical cancer screening

Among 425 study participants, only 12.2% of women have been screened within the past 3 years as illustrated in Fig. 1. The proportion of women who are screened at the age of 18–29 was 8% which was lower than women aged 30–39 (11.9%) and 40–49 (36.1%). Logistic regression analysis identified that, geographically, women who live in rural area were less likely to be screened [OR = 0.30, 95% CI: (0.11–0.85)] than women who live in urban area. Regarding respondents’ age, women in the 40–49 years age group were more likely to undergo cervical cancer screening practice [OR = 3.58, 95% CI: (1.21–10.58)] compared with women aged 18–29 years old. Additionally, the respondents’ screening was differed by occupation, self-employed women were more likely to be screened [OR = 2.58, 95% CI: (1.06–6.27)] than governmental employed women. Compared with nulliparous women, multiparous women more likely participated in cervical cancer screening [OR = 2.79, 95% CI: (1.05–7.39)]. Regarding income of respondents, women who had been earned 3000–3999 Birr (111–148 USA dollar) per month [OR = 2.93, 95% CI: (1.32–6.51)] and those who had earned greater than 4000 Birr (148 USA dollar) [OR = 2.97, 95% CI: (1.27–6.92)] were more likely seeking for screening than women who had been earned less than 2000 Birr (75 USA dollar) per month. However, marital status and educational level of respondents didn’t show significant association (P > 0.05) as shown in Table 2.

Fig. 1.

Fig. 1

Cervical screening status: Cervical cancer screening practice of participants during last 3 years

Table 2.

Socio-demographic characteristics and participation in cervical screening during last 3 years: Logistic regression

Characteristics Unscreened
n (%)
Screened
n (%)
Odds ratios
Crude
(95% CI)
Adjusted
(95% CI)
Age
 18–29 year 172 (92.0) 15 (8.0) 1.00 1.00
 30–39 year 178 (88.1) 24 (11.9) 1.55 (0.79–3.05) 1.05 (0.48–2.30)
 40–49 year 23 (63.9) 13 (36.1) 6.48 (2.74–15.33) 3.58 (1.21–10.58)*
Marital status
 Single 70 (93.3) 5 (6.7) 1.00 1.00
 Married 291 (87.4) 42 (12.6) 2.02 (0.77–5.29) 1.44 (0.46–4.55)
 Divorce or Windowed 12 (70.6) 5 (29.4) 5.83 (1.46–23.25) 1.52 (0.27–8.46)
Educational level
 Primary and below level 121 (96.0) 5 (4.0) 1.00 1.00
 Secondary and above 252 (84.3) 47 (15.7) 4.51 (1.75–11.64) 2.71 (0.94–7.79)
Occupation
 Governmental 85 (90.4) 9 (9.6) 1.00 1.00
 Self-employed 135 (83.3) 27 (16.7) 1.89 (0.85–4.21) 2.58 (1.06–6.27)*
 Housewife 153 (90.5) 16 (9.5) 0.99 (0.42–2.33) 1.45 (0.56–3.78)
Parity
 Nulliparous 126 (94.0) 8 (6.0) 1.00 1.00
 1–2 birth 202 (86.0) 33 (14.0) 2.57 (1.15–5.75) 2.79 (1.05–7.39)*
 3 and above 45 (80.4) 11 (19.6) 3.85 (1.46–10.18) 3.31 (0.94–11.59)
Monthly income
 < 2000 Birr 221 (94.0) 14 (6.0) 1.00 1.00
 2000–3999 Birr 85 (81.0) 20 (19.0) 3.71 (1.79–7.69) 2.93 (1.32–6.51)*
 4000 and above Birr 67 (78.8) 18 (21.2) 4.24 (2.00–8.98) 2.97 (1.27–6.92)*
Residence
 Urban 249 (84.1) 47 (15.9) 1.00 1.00
 Rural 124 (96.1) 5 (3.9) 0.21 (0.08–0.55) 0.30 (0.11–0.85)*

*statistically significant at P value < 0.05

Risk factors and cervical screening practice

Study participants who exposed to cervical cancer risks had low participation in cervical screening. Table 3 indicates that the risk factor and cervical screening practice of participants. According to this study, among screened women, 23.1% had a history of sexual contact before 18 years old. Besides, 57.7% of screened women didn’t use the condom during sexual contact. Also, 28.8% of screened women had a history of either hypertension, diabetes, infertility or irregular menses cases.

Table 3.

Risk factors and cervical screening practice

Risk factors Screening status
Unscreened
n (%)
Screened
n (%)
Age at first sex, < 18-year-old
 No 274 (73.5) 40 (76.9)
 Yes 99 (26.5) 12 (23.1)
Multiple sexual partners
 No 332 (89.0) 40 (76.9)
 Yes 41 (11.0) 12 (23.1)
Frequency of condom use
 Not use 260 (69.7) 30 (57.7)
 Occasionally 87 (23.3) 15 (28.8)
 Always 26 (7.0) 7 (13.5)
History of smoking
 No 363 (97.3) 51 (98.1)
 Yes 10 (2.7) 1 (1.9)
COC pills use
 No 161 (43.2) 23 (44.2)
 < 1 year 95 (25.5) 7 (13.5)
 > 1 year 117 (31.4) 22 (42.3)
History of STD
 No 348 (93.3) 45 (86.5)
 Yes 25 (6.7) 7 (13.5
HIV test
 No 25 (6.7) 0 (0.0)
 Yes 348 (93.3) 52 (100.0)
HIV status (N = 400)
 Negative 333 (89.3) 47 (95.7)
 Positive 15 (4.0) 5 (4.3)
History of HPT, DM, IF or IM
 No 296 (79.4) 37 (71.2)
 Yes 77 (20.6) 15 (28.8)

COC Combined oral contraceptive, STD Sexually transmitted disease, HPT Hypertension, DM Diabetic mellitus, IF Infertility, IM Irregular menses

Knowledge and perception factors associated with cervical screening during the last 3 years

Regarding knowledge of cervical cancer screening, women who heard cervical cancer screening benefits were more likely to be screened [OR = 4.11, 95% CI: (1.12–15.04)] than those who had not. Respondents who knew about precancerous cervical dysplasia which could happen without symptoms were more likely to be screened [OR = 2.09, 95% CI: (1.06–4.10)] than women who didn’t know.

Women who agreed by the thought that “I can’t do screening even though beneficial” were less likely to be screened [OR = 0.10, 95% CI: (0.02–0.43)] as compared with counterparts. Women who likely felt the possibility of getting cervical cancer were more likely to be screened than counterparts [OR = 5.36, 95% CI: (2.12–13.55)]. Also, those who perceived the chance of getting cervical cancer were more likely to be screened [OR = 3.40, 95% CI: (1.51–7.69)] as compared with women who unlikely perceived (Table 4).

Table 4.

Knowledge and perception factors associated with cervical screening during the last 3 years

Characteristics Unscreened
n (%)
Screened
n (%)
Odds ratios
Crude
(95% CI)
Adjusted
(95% CI)
Heard about cervical cancer
 No 151 (40.5) 7 (13.5) 1.00 1.00
 Yes 222 (59.5) 45 (86.5) 4.37 (1.92–9.96) 0.59 (0.16–2.18)
Heard about CC screening
 No 179 (48.0) 6 (11.5) 1.00 1.00
 Yes 194 (52.0) 46 (88.5) 7.07 (2.95–16.96) 4.11 (1.12–15.04)*
PCD can happen without symptom
 No 262 (70.2) 21 (40.4) 1.00 1.00
 Yes 111 (29.8) 31 (59.6) 3.48 (1.92–6.33) 2.07 (1.06–4.10)*
CC is killer, if undetected and untreated early
 Disagree 36 (9.7) 2 (3.8) 1.00 1.00
 Agree 226 (60.6 44 (84.6) 3.50 (0.81–15.09) 3.64 (0.75–17.59)
 I don’t know 111 (29.8) 6 (11.5) 0.97 (0.19–5.04) 1.27 (0.205–7.85)
Overall Knowledge about cervical cancer
 Not knowledgeable 298 (79.9) 21 (40.4) 1.00 1.00
 Knowledgeable 75 (20.1) 31 (59.6) 5.87 (3.19–10.79) 2.48 (1.18–5.19)*
Like many women, I am susceptible to CC.
 No 161 (43.2) 10 (19.2) 1.00 1.00
 Yes 212 (56.8) 42 (80.8) 3.19 (1.55–6.55) 1.36 (0.57–3.26)
Even if I see screening is beneficial, I can’t do so.
 Disagree 254 (68.1) 43 (82.7) 1.00 1.00
 Agree 104 (27.9) 2 (3.8) 0.11 (0.03–0.48) 0.10 (0.02–0.43)*
 Indifferent 15 (4.0) 7 (13.5) 2.76 (1.06–7.15) 3.87 (1.16–12.86)*
Chance of getting CC.
 Unlikely 278 (74.5) 17 (74.5) 1.00 1.00
 Somewhat 63 (16.9) 20 (16.9 5.19 (2.57–10.48) 3.41 (1.51–7.69)*
 Likely 32 (8.6) 15 (8.6) 7.67 (3.49–16.80) 5.36 (2.12–13.55)**

CC Cervical Cancer, PCD Pre-malignant cervical cancer dysplasia

**Statistically significant at P value < 0.001, *Significant at P value < 0.05

Barrier factors and participation in cervical screening during the last 3 years

Women who fear the test outcome of cervical cancer were less likely to be screened [OR = 0.50, 95% CI: (0.23–0.92)] than women who didn’t fear. Based on cervical screening information, those who had its information more likely to be screened [OR = 2.01, 95% CI: (1.03–3.95] as compared with women who need more information. Respondents who knew the place of cervical screening services were more likely to be screened [OR = 11.83, 95% CI: (3.54–39.51)] than those who didn’t know. Furthermore, women who had a history of cervical illness were more likely to be screened [OR = 8.64, 95% CI: (2.36–31.63)] as compared with women who felt healthiness (Table 5).

Table 5.

Association between barrier factors and cervical screening (n = 425)

Barrier factors Unscreened
n (%)
Screened
n (%)
Odds ratios
Crude
(95% CI)
Adjusted
(95% CI)
Fear test outcomes
 No 221 (59.2) 40 (76.9) 1.00 1.00
 Yes 152 (40.8) 12 (23.1) 0.44 (0.22–0.86) 0.47 (0.23–0.92)*
Is a test too embarrassing
 No 313 (83.9) 44 (84.6) 1.05 (0.47–2.35) 2.31 (0.93–5.75)
 Yes 60 (16.1) 8 (15.4) 1.00 1.00
Need more information
 No 141 (37.8) 24 (46.2) 1.41 (0.79–2.53) 2.01 (1.03–3.95)*
 Yes 232 (62.2) 28 (53.8) 1.00 1.00
Difficult to talk to a provider
 No 321 (86.1) 41 (78.8) 0.60 (0.29–1.25) 0.61 (0.27–1.42)
 Yes 52 (13.9) 11 (21.2) 1.00 1.00
Don’t know where to get the service
 No 227 (60.9) 49 (94.2) 10.51 (3.22–34.33) 11.83 (3.54–39.51)**
 Yes 146 (39.1) 3 (5.8) 1.00 1.00
Clinic far from home
 No 290 (77.7) 46 (88.5) 2.19 (0.91–5.32) 2.17 (0.81–5.81)
 Yes 83 (22.3) 6 (11.5) 1.00 1.00
Perceived poor quality of service
 No 305 (81.8) 37 (71.2) 0.55 (0.29–1.06) 0.60 (0.28–1.27)
 Yes 68 (18.2) 15 (28.8) 1.00 1.00
I had never Hx of cervical illness
 No 292 (78.3) 49 (94.2) 4.53 (1.38–14.91) 8.64 (2.36–31.63)*
 Yes 81 (21.7) 3 (5.8) 1.00 1.00

Hx History

**Statistically significant at P value < 0.001, *Significant at P value < 0.05

Discussions

Cervical cancer screening is the easiest, simple and easily affordable choice to prevent and reduce maternal mortality associated with cervical cancer. This study found that only 12.2% of women had a practice of cervical cancer screening; however, this finding is higher than the national data reported by the Institute Catalan of Oncology (ICO) in 2017 which showed that cervical screening practices in Ethiopia were less than 1% [8]. The differences might be due to the countrywide report, poor registration system or the study setup. But, it is in line with the finding of a study in the Southern part of Ethiopia (11.5%) [23]. However, it is lower than the finding of a study done in the Northern part of Ethiopia (19.8%) [22]. This might be due to the difference in the study setup, or the former study was conducted at the place where one of the pilot projects allocated areas in the country. This made better screening access for women participated in the former study. Similarly, the present finding is also significantly lower than the finding of Portland Jamaica study (66%) [6]. This variability might be due to inadequate access to health facility, screening tools, skilled professionals, better governmental concern to cervical cancer prevention and control, and availability of Pap test at the health institution.

Our study found that age was significantly associated with the uptake of cervical cancer screening. The study revealed that women in the youngest age (18–29 years) were less likely to be screened compared with women in the older age (40–49 years). The finding was similar to studies done in South Africa and Portland Jamaica [6, 20]. Older women have a higher likelihood to develop cervical cancer than younger, however, it is important to consider as they are sexually active.

Rural residence was significantly associated with low uptake of screening in this study. Related studies were done in Nepal [19] and Uganda [24] showed that rural women were less likely to receive screening. Another study conducted in Mexico revealed that women who reside in rural areas had a significantly greater geographic accessibility burden when compared to non-rural areas (4.4 km vs 2.5 km and 4.9 min vs 3.0 min) for screening due to these rural women were less likely underwent to cervical screening [25]. In Ethiopia, most screening facilities were available in urban hospitals while 80% of the population lives in rural areas; on the other hand, those hospitals were overburdened by advanced cases/chronic diseases; because of this reason, the participation in screening is compromised. Therefore, it needs to address the rural population by decentralizing the service to rural health centers.

This study found that nulliparous women were associated with the low uptake of cervical cancer screening, which means nulliparous women were less likely screened than multiparous women. This finding is consistent with a study conducted in Thailand that revealed women who had no children had less practice of cervical screening [26]. Underuse of screening nulliparous women is not a significant public health concern while they are less likely a chance to develop the disease compared to multiparous women. However, it is important to engage those women in prevention activities as all women are at risk of cervical cancer.

Occupational status significantly influences the uptake of cervical cancer screening in this study; which means self-employed women were more likely to be screened compared with governmental employed women. This finding concurs with a study conducted in Northern Greece which reported that women with full-time employees had higher compliance to participate in cervical screening [27]. This is might be due to those government workers have no time to go or maybe due to negligence, therefore it is better to address effective intervention including cervical cancer awareness and preventive measures.

In this study, women who had low monthly income were significantly associated with low uptake of cervical cancer screening. This finding is argued with a study done in Ontario that showed women with low monthly income were less likely engaging in cervical screening [28]. Also, a study conducted in Belgrade reported that lower economic status has a great impact on cervical screening even fee-free available services [29]. In fact, in Ethiopia, cervical screening service is freely available but different reasons are identified as limitations to use the service among low-income women; for instance, transportation fees, childcare cost, and frequent attending to the subsequent follow-up visit.

Lack of information towards cervical screening benefits could influence the uptake of screening. This study found that respondents who had no information about cervical cancer screening benefit less participated in cervical screening. A related study from Omaha Nebraska stated that the majority of women in the study never heard about cervical cancer and they had less practice of pap test [30]. Therefore, providing relevant information on screening and its benefit from concerned stakeholders is crucial to ensure cervical cancer screening.

This study also found a significant association between knowledge of premalignant dysplasia and uptake of cervical screening. Our study showed that the majority of respondents didn’t have knowledge of the occurrence of pre-malignant dysplasia without signs or symptoms, in contrast, women who knew about the pre-cancerous condition of cervical cancer were more likely to be screened compared with women who didn’t. A study from Kisumu Kenya showed that 63.2% of the respondents had no knowledge regarding signs and symptoms of cervical cancer and had less practice of cervical cancer screening [31].

There were strong associations between self-perceived to get cervical cancer and uptake of screening in this survey; which means women who perceived unlikely to get cervical cancer had been less likely screened. A qualitative study conducted in the British showed that women who felt the low perceived risk of cancer were less likely to be screened [32]. Additional studies from Vietnamese Americans [33] and qualitative study from Kurdish described that women who believed as a lower risk group of getting cancer were less willing to perform the test [34]. This perception might be related to religion or belief in destiny; therefore, the participation of religious leaders in controlling the cervical cancer program is better.

Moreover, the current study showed that the test result was a significant barrier to the uptake of cervical cancer screening; which means women who fear test outcome cervical cancer had less practice of cervical screening. Besides, barrier factors such as lack of information, unknown place of service, and felt wellness were shows significant association with low screening uptake. These findings have also been documented in other studies [22, 24, 33] Therefore, it needs to address these barriers to increase the uptake of screening practice.

This study has some limitations. It is a hospital-based study that is difficult to represent the entire population. It has a small sample size that can reduce statistical power and generalization. Other limitations of this study are recall bias and selection bias. As the sampling method of this study was purposive, it might be led to selection bias and decrease reliability. Lack of RR analysis methods also another limitation of this study as RRs would fit with common outcomes rather than OR in which some of the point estimates are not easy to interpret. The cross-sectional design investigates prevalence and associations rather than causality. Thus, future research needs to replicate these findings using prospective studies/longitudinal study design. A high percentage of the participation rate is considered the strength of this study.

Conclusion

This study aimed to determine the influence of sociodemographic characteristics and related factors for the low uptake of cervical cancer screening among women. Based on our study findings, women in the potential target population of cervical cancer screening were just a proportion of all studied age groups and screening in them was more common than in younger women. In addition, rural residence, low monthly income, governmental employee, lack of knowledge and wrong perception towards cervical cancer were significantly associated with the low uptake of cervical cancer screening. Therefore, we suggest that improving the health care system by giving due attention to the rural residence, low-income population, awareness creation towards screening, and associated risk factors including delivering the service to the government employee in their workplace. Furthermore, our study contributes insightful basis to develop strategies to prevent and control cervical cancer based on the sociodemographic profile.

Acknowledgments

We would like to thanks all staff members at St. Paul’s Hospital and all study participants for their valuable contribution during data collection.

Abbreviations

CC

Cervical cancer

COC

Combined oral contraceptive

DM

Diabetes mellitus

FMOH

Federal Ministry of Health

HIV

Human Immune deficiency Virus

HPV

Human Papilloma Virus

IARC

International Agency for Research on Cancer

ICO

Institute Catalan of Oncology

IF

Infertility

IM

Irregular menses

STRH

St. Paul’s Teaching and Referral Hospital

VIA

Visual Inspection Acetic acid

WHO

World Health Organization

Authors’ contributions

ABW, and AFA: Study design, data analysis, and manuscript draft and writing. STB, and JL: data analysis/interpretation/, draft and revised the manuscript. LLP: Statistical analysis and interpretation. JH: Study concept, technical support, and manuscript revision and supervised the whole study. All authors read and approved the final manuscript.

Funding

This work was supported by the Shenzhen Science and Technology Project (JCYJ20170816100755047). The study sponsors did not involve in the study design, data collection, analysis or interpretation, or in the writing of the manuscript, neither did they affect the decision to submit the manuscript for publication.

Availability of data and materials

Data are available from abwolde69@gmail.com on a reasonable request.

Ethics approval and consent to participate

Ethical approval was obtained from Xi’an Jiaotong University and Institutional Review Board of St. Paul’s Hospital Millennium Medical College of Health Science (ref no. pm23/7) before starting the actual research data collection. A letter of consent was written to the medical director and hospital administration offices to have the desired cooperation and participation of the study participants. Before the interview, verbal consent has been obtained from participant as some of participants were unable to read and write. This method was approved by Institutional Review Board of St. Paul’s Hospital Millennium Medical College of Health Science. Participants was assured about the confidentiality of the information. All participants were voluntary for this study.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abebe Belete Woldetsadik and Abebe Feyissa Amhare contributed equally to this work.

Contributor Information

Abebe Belete Woldetsadik, Email: belete163@yahoo.com.

Abebe Feyissa Amhare, Email: abebefeyissa21@gmail.com.

Sintayehu Tsegaye Bitew, Email: sintayehutsegaye288@yahoo.com.

Leilei Pei, Email: 109142175@qq.com.

Jian Lei, Email: 517328639@qq.com.

Jing Han, Email: bbbishop@126.com.

References

  • 1.Parkhurst JO, Vulimiri M. Cervical cancer and the global health agenda: insights from multiple policy-analysis frameworks. Global Public Health. 2013;8(10):1093–1108. doi: 10.1080/17441692.2013.850524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.International Agency for Research on Cancer. Global cancer observatory. World Health Organization. http://gco.iarc.fr. Accessed 8 Nov 2018.
  • 3.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. [DOI] [PubMed] [Google Scholar]
  • 4.Luciani S, Cabanes A, Prieto-Lara E, Gawryszewski V. Cervical and female breast cancers in the Americas: current situation and opportunities for action. Bull World Health Organ. 2013;91(9):640–649. doi: 10.2471/BLT.12.116699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lyimo FS, Beran TN. Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: three public policy implications. BMC Public Health. 2012;12(1):22–30. doi: 10.1186/1471-2458-12-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ncube B, Bey A, Knight J, Bessler P, Jolly PE. Factors associated with the uptake of cervical cancer screening among women in Portland, Jamaica. N Am J Med Sci. 2015;7(3):104–113. doi: 10.4103/1947-2714.153922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Belete N, Tsige Y, Mellie H. Willingness and acceptability of cervical cancer screening among women living with HIV/AIDS in Addis Ababa, Ethiopia: a cross sectional study. Gynecol Oncol Res Pract. 2015;2(1):6. doi: 10.1186/s40661-015-0012-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Ethiopia. Summary Report. 2017. p. 58–9.
  • 9.Kress CM, Sharling L, Owen-Smith AA, Desalegn D, Blumberg HM, Goedken J. Knowledge, attitudes, and practices regarding cervical cancer and screening among Ethiopian health care workers. Int J Women's Health. 2015;7:765–772. doi: 10.2147/IJWH.S85138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hailemariam T, Yohannes B, Aschenaki H, Mamaye E, Orkaido G, Seta M. Prevalence of cervical cancer and associated risk factors among women attending cervical cancer screening and diagnosis center at Yirgalem General Hospital, southern Ethiopia. J Cancer Sci Ther. 2017;9(11):730–735. doi: 10.4172/1948-5956.1000500. [DOI] [Google Scholar]
  • 11.Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S, Brotons M, Mena M, Cosano R, Muñoz J. Human papillomavirus and related diseases in the world. ICO Information Centre on HPV and Cancer (HPV Information Centre) 2015. pp. 04–08. [Google Scholar]
  • 12.Chadza E, Chirwa E, Maluwa A, Kazembe A, Chimwaza A. Factors that contribute to delay in seeking cervical cancer diagnosis and treatment among women in Malawi. Health (N Y) 2012;4(11):1015–1022. [Google Scholar]
  • 13.Singh S, Badaya S. Factors influencing uptake of cervical cancer screening among women in India: a hospital based pilot study. J Community Med Health Educ. 2012;2(157):2161–0711.1000157. [Google Scholar]
  • 14.Abate S. Trends of cervical cancer in Ethiopia. Gynecol Obstet (Sunnyvale) 2015;5(103):2161–0932. [Google Scholar]
  • 15.International Agency for Research on Cancer Lyon FI: IARC handbook of cancer prevention. Cervical Cancer. 2005;10:201–226. [Google Scholar]
  • 16.Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ. 2001;79:954–962. [PMC free article] [PubMed] [Google Scholar]
  • 17.Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, Von Karsa L. European guidelines for quality assurance in cervical cancer screening —summary document. Ann Oncol. 2010;21(3):448–458. doi: 10.1093/annonc/mdp471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Finocchario-Kessler S, Wexler C, Maloba M, Mabachi N, Ndikum-Moffor F, Bukusi E. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health. 2016;16(1):29–54. doi: 10.1186/s12905-016-0306-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ranabhat S, Tiwari M, Dhungana G, Shrestha R. Association of knowledge, attitude and demographic variables with cervical Pap smear practice in Nepal. Asian Pac J Cancer Prev. 2014;15(20):8905–8910. doi: 10.7314/APJCP.2014.15.20.8905. [DOI] [PubMed] [Google Scholar]
  • 20.Peltzer K, Phaswana-Mafuya N. Breast and cervical cancer screening and associated factors among older adult women in South Africa. Asian Pac J Cancer Prev. 2014;15(6):2473–2476. doi: 10.7314/APJCP.2014.15.6.2473. [DOI] [PubMed] [Google Scholar]
  • 21.Frett B, Aquino M, Fatil M, Seay J, Trevil D, Fièvre MJ, Kobetz E. Get vaccinated! and get tested! Developing primary and secondary cervical cancer prevention videos for a Haitian Kreyòl-speaking audience. J Health Commun. 2016;21(5):512–516. doi: 10.1080/10810730.2015.1103330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bayu H, Berhe Y, Mulat A, Alemu A. Cervical cancer screening service uptake and associated factors among age eligible women in Mekelle zone, northern Ethiopia, 2015: a community based study using health belief model. PLoS One. 2016;11(3):e0149908. doi: 10.1371/journal.pone.0149908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dulla D, Daka D, Wakgari N. Knowledge about cervical cancer screening and its practice among female health care workers in southern Ethiopia: a cross-sectional study. Int J Women's Health. 2017;9:365–372. doi: 10.2147/IJWH.S132202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ndejjo R, Mukama T, Musabyimana A, Musoke D. Uptake of cervical cancer screening and associated factors among women in rural Uganda: a cross sectional study. PLoS One. 2016;11(2):e0149696. doi: 10.1371/journal.pone.0149696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.McDonald YJ, Goldberg DW, Scarinci IC, Castle PE, Cuzick J, Robertson M, Wheeler CM. Health service accessibility and risk in cervical cancer prevention: comparing rural versus nonrural residence in New Mexico. J Rural Health. 2017;33(4):382–392. doi: 10.1111/jrh.12202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wongwatcharanukul L, Promthet S, Bradshaw P, Jirapornkul C, Tungsrithong N. Factors affecting cervical cancer screening uptake by Hmong hilltribe women in Thailand. Asian Pac J Cancer Prev. 2014;15:3753–3756. doi: 10.7314/APJCP.2014.15.8.3753. [DOI] [PubMed] [Google Scholar]
  • 27.Vakfari A, Gavana M, Giannakopoulos S, Smyrnakis E, Benos A. Participation rates in cervical cancer screening: experience in rural northern Greece. Hippokratia. 2011;15(4):346–352. [PMC free article] [PubMed] [Google Scholar]
  • 28.Elit L, Saskin R, Raut R, Elliott L, Murphy J, Marrett L. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort. Gynecol Oncol. 2013;128(1):95–100. doi: 10.1016/j.ygyno.2012.10.006. [DOI] [PubMed] [Google Scholar]
  • 29.Matejic B, Vukovic D, Pekmezovic T, Kesic V, Markovic M. Determinants of preventive health behavior in relation to cervical cancer screening among the female population of Belgrade. Health Educ Res. 2011;26(2):201–211. doi: 10.1093/her/cyq081. [DOI] [PubMed] [Google Scholar]
  • 30.Haworth RJ, Margalit R, Ross C, Nepal T, Soliman AS. Knowledge, attitudes, and practices for cervical cancer screening among the Bhutanese refugee community in Omaha, Nebraska. J Community Health. 2014;39(5):872–878. doi: 10.1007/s10900-014-9906-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Morema ENAH, Onyango RO, Omondi JH, Ouma C. Determinants of cervical screening services uptake among 18–49 year old women seeking services at the Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya. BMC Health Serv Res. 2014;14(1):335–342. doi: 10.1186/1472-6963-14-335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Marlow LA, Waller J, Wardle J. Barriers to cervical cancer screening among ethnic minority women: a qualitative study. J Fam Plann Reprod Health Care. 2015;41(4):248–254. doi: 10.1136/jfprhc-2014-101082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ma GX, Gao W, Fang CY, Tan Y, Feng Z, Ge S, Nguyen JA. Health beliefs associated with cervical cancer screening among Vietnamese Americans. J Women's Health. 2013;22(3):276–288. doi: 10.1089/jwh.2012.3587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Rasul V, Cheraghi M, Moqadam ZB. Influencing factors on cervical cancer screening from the Kurdish women’s perspective: a qualitative study. J Med Life. 2015;8(Spec Iss 2):47–54. [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data are available from abwolde69@gmail.com on a reasonable request.


Articles from BMC Women's Health are provided here courtesy of BMC

RESOURCES